Cancer and Ketogenic Metabolic Therapy: Research Updates and Practical Tips

Wishlist Share
Share Course
Page Link
Share On Social Media

About Course

Ketogenic diets are well known for their effective role as a treatment for refractory epilepsy but they have gained popularity in the oncology world in recent years. Join Registered Dietitians L.J. Amaral MS, RD, CSO who specializes in oncology and is the founder of Oncology Nutritional Science by L.J., and Denise Potter RDN, CSP, CDE founder of Potter Dietitian Consulting. They will take a deep dive into this controversial topic by discussing the most up-to-date research behind ketogenic metabolic therapy for oncology patients. Safety, effectiveness, and appropriateness of ketogenic metabolic therapy will be covered. The presenters will guide listeners on candidate selection from a clinical standpoint with consideration of social aspects.  After reviewing the unbiased research, the presenters will discuss practical aspects including the implementation and prevention of common side effects of ketogenic metabolic therapy. They will also discuss interactions/barriers in regards to ketogenic metabolic therapy and cancer treatments and associated side effects. Finally, the presenters will review appropriate monitoring and follow-up care.

References: Cancer and the Ketogenic Metabolic Therapy References

APPROVED FOR 1 CPE CREDIT BY THE CDR OF THE ACADEMY OF NUTRITION AND DIETETICS
RDs may claim CE credit for this webinar until 10/27/2025.


Make sure to check to out the Continuing Education Guide for instructions on how to complete and earn your credit for this course!

Show More

What Will You Learn?

  • Participants will understand the history and most up-to-date research of ketogenic metabolic therapy and oncology.
  • Participants will be able to identify appropriate candidates for ketogenic metabolic therapy.
  • Participants will gain practical tips on ketogenic metabolic therapy to help promote success and reduce risk of associated side effects.
  • Participants will identify monitoring criteria for ketogenic metabolic therapy for the oncology population as well as research-based resources for further